{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:42:43Z","timestamp":1787024563698,"version":"build-2736575974"},"reference-count":28,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["OPTH"],"DOI":"10.2147\/opth.s259331","type":"journal-article","created":{"date-parts":[[2020,9,20]],"date-time":"2020-09-20T19:10:51Z","timestamp":1600629051000},"page":"2747-2755","source":"Crossref","is-referenced-by-count":11,"title":["<p>Preclinical Efficacy Comparison of Cyclosporine Ophthalmic Solution 0.09% vs Cyclosporine Ophthalmic Emulsion 0.05% vs Ciclosporin Ophthalmic Emulsion 0.1% in a NOD Mouse Model of Dry Eye Disease<\/p>"],"prefix":"10.2147","volume":"Volume 14","author":[{"given":"Vinod","family":"Burade","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rishit","family":"Zalawadia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alpesh","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abayomi","family":"Ogundele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2020,9]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.jtos.2017.05.008","volume":"15","author":"Craig","year":"2017","journal-title":"Ocul Surf"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/j.jtos.2017.08.003","volume":"15","author":"Craig","year":"2017","journal-title":"Ocul Surf"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.jtos.2017.05.006","volume":"15","author":"Jones","year":"2017","journal-title":"Ocul Surf"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.ajo.2003.10.036","volume":"137","author":"Pflugfelder","year":"2004","journal-title":"Am J Ophthalmol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.2147\/OPTH.S175065","volume":"12","author":"Tauber","year":"2018","journal-title":"Clin Ophthalmol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/S0161-6420(99)00176-1","volume":"107","author":"Sall","year":"2000","journal-title":"Ophthalmology"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"678","DOI":"10.5301\/ejo.5001002","volume":"27","author":"Baudouin","year":"2017","journal-title":"Eur J Ophthalmol"},{"key":"ref8","unstructured":"Sun Pharmaceutical Industries, Inc. CEQUA\u2122 (Cyclosporine Ophthalmic Solution 0.09%). Full Prescribing Information. Cranbury, NJ: Sun Pharmaceutical Industries, Inc; 2018."},{"key":"ref9","unstructured":"Allergan. RESTASIS\u00ae (Cyclosporine Ophthalmic Emulsion) 0.05% for Topical Ophthalmic Use. Full prescribing information. Irvine, CA: Allergan; 2017."},{"key":"ref10","unstructured":"Santen SAS. IKERVIS\u00ae (Ciclosporin Ophthalmic Emulsion) 1 Mg\/Ml, for Topical Ophthalmic Use. Full prescribing information. Evry, France: Santen SAS; 2015."},{"key":"ref11","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.ejpb.2017.03.006","volume":"117","author":"Lallemand","year":"2017","journal-title":"Eur J Pharm Biopharm"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1002\/wnan.1272","volume":"6","author":"Vaishya","year":"2014","journal-title":"Wiley Interdiscip Rev Nanomed Nanobiotechnol"},{"key":"ref13","first-page":"209","volume":"37","author":"Xiao","year":"2019","journal-title":"Clin Exp Rheumatol"},{"key":"ref14","first-page":"47","author":"Vitali","year":"2016","journal-title":"In: Sj\u00f6gren\u2019s Syndrome Elsevier"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.jtos.2017.05.011","volume":"15","author":"Bron","year":"2017","journal-title":"Ocul Surf"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.ajpath.2013.03.017","volume":"183","author":"Marko","year":"2013","journal-title":"Am J Pathol"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.ajpath.2013.11.019","volume":"184","author":"McClellan","year":"2014","journal-title":"Am J Pathol"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1097\/ICO.0000000000001989","volume":"38","author":"Malhotra","year":"2019","journal-title":"Cornea"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"S14","DOI":"10.1097\/ICL.0000000000000636","volume":"46","author":"Sheppard","year":"2020","journal-title":"Eye Contact Lens"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1016\/j.ophtha.2019.03.050","volume":"126","author":"Goldberg","year":"2019","journal-title":"Ophthalmology"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"887","DOI":"10.2147\/OPTH.S101627","volume":"10","author":"Stonecipher","year":"2016","journal-title":"Clin Ophthalmol"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1136\/bjophthalmol-2017-311801","volume":"103","author":"Leonardi","year":"2019","journal-title":"Br J Ophthalmol"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.preteyeres.2016.04.005","volume":"54","author":"Gipson","year":"2016","journal-title":"Prog Retin Eye Res"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/978-3-030-21735-8_3","volume":"1161","author":"Dartt","year":"2019","journal-title":"Adv Exp Med Biol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.98222","volume":"3","author":"Ko","year":"2018","journal-title":"JCI Insight"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1001\/archopht.120.3.330","volume":"120","author":"Kunert","year":"2002","journal-title":"Arch Ophthalmol"},{"key":"ref27","first-page":"299","volume":"14","author":"Ralph","year":"1975","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1038\/eye.2011.184","volume":"25","author":"Hamrah","year":"2011","journal-title":"Eye"}],"container-title":["Clinical Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=61606","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=61606","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,20]],"date-time":"2020-09-20T19:10:55Z","timestamp":1600629055000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/preclinical-efficacy-comparison-of-cyclosporine-ophthalmic-solution-00-peer-reviewed-article-OPTH"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":28,"URL":"https:\/\/doi.org\/10.2147\/opth.s259331","relation":{},"ISSN":["1177-5483"],"issn-type":[{"value":"1177-5483","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9]]}}}